553 related articles for article (PubMed ID: 27452466)
21. Distinct regulation of ASCL1 by the cell cycle and chemotherapy in small cell lung cancer.
Liu Y; Wu Q; Jiang B; Hou T; Wu C; Wu M; Song H
Mol Cancer Res; 2024 Mar; ():. PubMed ID: 38512021
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy.
Biswas S; Kang K; Ng KP; Radivoyevitch T; Schalper K; Zhang H; Lindner DJ; Thomas A; MacPherson D; Gastman B; Schrump DS; Wong KK; Velcheti V; Saunthararajah Y
Cell Rep; 2023 Aug; 42(8):113016. PubMed ID: 37597186
[TBL] [Abstract][Full Text] [Related]
23. Lineage-specific intolerance to oncogenic drivers restricts histological transformation.
Gardner EE; Earlie EM; Li K; Thomas J; Hubisz MJ; Stein BD; Zhang C; Cantley LC; Laughney AM; Varmus H
Science; 2024 Feb; 383(6683):eadj1415. PubMed ID: 38330136
[TBL] [Abstract][Full Text] [Related]
24. A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma.
Cai L; DeBerardinis RJ; Xie Y; Minna JD; Xiao G
Mol Cancer Res; 2023 Aug; 21(8):795-807. PubMed ID: 37255415
[TBL] [Abstract][Full Text] [Related]
25. Bromodomain Protein-directed Agents and MYC in Small Cell Lung Cancer.
Hamilton G; Stickler S; Rath B
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38275056
[TBL] [Abstract][Full Text] [Related]
26. Genome Wide Association Studies in Small-Cell Lung Cancer. A Systematic Review.
Enjo-Barreiro JR; Ruano-Ravina A; Pérez-Ríos M; Kelsey K; Barros-Dios JM; Varela-Lema L
Clin Lung Cancer; 2024 Jan; 25(1):9-17. PubMed ID: 37940411
[TBL] [Abstract][Full Text] [Related]
27. PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacity.
Varuzhanyan G; Chen CC; Freeland J; He T; Tran W; Song K; Wang L; Cheng D; Xu S; Dibernardo GA; Esedebe FN; Abt ER; Park JW; Memarzadeh S; Graeber T; Shirihai O; Witte O
bioRxiv; 2024 Apr; ():. PubMed ID: 38645232
[TBL] [Abstract][Full Text] [Related]
28. Data-driven structural analysis of small cell lung cancer transcription factor network suggests potential subtype regulators and transition pathways.
Ozen M; Lopez CF
NPJ Syst Biol Appl; 2023 Oct; 9(1):55. PubMed ID: 37907529
[TBL] [Abstract][Full Text] [Related]
29. ASCL1 characterizes adrenergic neuroblastoma via its pioneer function and cooperation with core regulatory circuit factors.
Wang L; Tan TK; Kim H; Kappei D; Tan SH; Look AT; Sanda T
Cell Rep; 2023 Dec; 42(12):113541. PubMed ID: 38060444
[TBL] [Abstract][Full Text] [Related]
30. FORMATION OF MALIGNANT, METASTATIC SMALL CELL LUNG CANCERS THROUGH OVERPRODUCTION OF cMYC PROTEIN IN TP53 AND RB1 DEPLETED PULMONARY NEUROENDOCRINE CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS.
Chen HJ; Gardner EE; Shah Y; Zhang K; Thakur A; Zhang C; Elemento O; Varmus H
bioRxiv; 2023 Oct; ():. PubMed ID: 37873210
[TBL] [Abstract][Full Text] [Related]
31. Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cancer.
Catozzi A; Peiris-Pagès M; Humphrey S; Revill M; Morgan D; Roebuck J; Chen Y; Davies-Williams B; Lallo A; Galvin M; Pearce SP; Kerr A; Priest L; Foy V; Carter M; Caeser R; Chan J; Rudin CM; Blackhall F; Frese KK; Dive C; Simpson KL
bioRxiv; 2024 Feb; ():. PubMed ID: 38405859
[TBL] [Abstract][Full Text] [Related]
32. Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer.
Chauhan L; Ram U; Hari K; Jolly MK
Elife; 2021 Mar; 10():. PubMed ID: 33729159
[TBL] [Abstract][Full Text] [Related]
33. Transcription factor dynamics, oscillation, and functions in human enteroendocrine cell differentiation.
Singh PNP; Gu W; Madha S; Lynch AW; Cejas P; He R; Bhattacharya S; Gomez MM; Oser MG; Brown M; Long HW; Meyer CA; Zhou Q; Shivdasani RA
bioRxiv; 2024 Jan; ():. PubMed ID: 38260422
[TBL] [Abstract][Full Text] [Related]
34. MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
Mollaoglu G; Guthrie MR; Böhm S; Brägelmann J; Can I; Ballieu PM; Marx A; George J; Heinen C; Chalishazar MD; Cheng H; Ireland AS; Denning KE; Mukhopadhyay A; Vahrenkamp JM; Berrett KC; Mosbruger TL; Wang J; Kohan JL; Salama ME; Witt BL; Peifer M; Thomas RK; Gertz J; Johnson JE; Gazdar AF; Wechsler-Reya RJ; Sos ML; Oliver TG
Cancer Cell; 2017 Feb; 31(2):270-285. PubMed ID: 28089889
[TBL] [Abstract][Full Text] [Related]
35. Unravelling the biology of SCLC: implications for therapy.
Sabari JK; Lok BH; Laird JH; Poirier JT; Rudin CM
Nat Rev Clin Oncol; 2017 Sep; 14(9):549-561. PubMed ID: 28534531
[TBL] [Abstract][Full Text] [Related]
36. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N
Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690
[TBL] [Abstract][Full Text] [Related]
37. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.
Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T
Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196
[TBL] [Abstract][Full Text] [Related]
38. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
[TBL] [Abstract][Full Text] [Related]
39. Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer.
Lim JS; Ibaseta A; Fischer MM; Cancilla B; O'Young G; Cristea S; Luca VC; Yang D; Jahchan NS; Hamard C; Antoine M; Wislez M; Kong C; Cain J; Liu YW; Kapoun AM; Garcia KC; Hoey T; Murriel CL; Sage J
Nature; 2017 May; 545(7654):360-364. PubMed ID: 28489825
[TBL] [Abstract][Full Text] [Related]
40. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Rudin CM; Poirier JT; Byers LA; Dive C; Dowlati A; George J; Heymach JV; Johnson JE; Lehman JM; MacPherson D; Massion PP; Minna JD; Oliver TG; Quaranta V; Sage J; Thomas RK; Vakoc CR; Gazdar AF
Nat Rev Cancer; 2019 May; 19(5):289-297. PubMed ID: 30926931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
